Adverse Events in Chronic Hemodialysis Patients Receiving Intravenous Iron Dextran – A Comparison of Two Products

Publisher： Karger

E-ISSN： 1421-9670|20|6|455-462

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.20, Iss.6, 2000-12, pp. : 455-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Weekly or Successive Iron Supplementation on Erythropoietin Doses in Patients Receiving Hemodialysis

By  

Nephron, Vol. 89, Iss. 1, 2001-08 ,pp. : 110-112

Karger

Access to resources Recommend Favorite

Intravenous Iron Sucrose in Chinese Hemodialysis Patients with Renal Anemia

By  

Blood Purification, Vol. 26, Iss. 2, 2008-01 ,pp. : 151-156

Karger

Access to resources Recommend Favorite

Intravenous Low-Dose Iron Administration in Hemodialysis Patients Treated with Erythropoietin

By  

Nephron, Vol. 80, Iss. 3, 1998-11 ,pp. : 369-370

Karger

Access to resources Recommend Favorite

Comparison and Reproducibility of Techniques for Fluid Status Assessment in Chronic Hemodialysis Patients

By  

Cardiorenal Medicine, Vol. 3, Iss. 2, 2013-05 ,pp. : 104-112

Karger

Access to resources Recommend Favorite

Non-Alcoholic Fatty Liver Disease Proven by Transient Elastography in Hemodialysis Patients: Is It a New Risk Factor for Adverse Cardiovascular Events?

By  

Blood Purification, Vol. 37, Iss. 4, 2014-07 ,pp. : 259-265

Karger

Access to resources Recommend Favorite